Background: In nondiabetic people, the long-term effects of insulin resistance (IR) on heart failure (HF) and all-cause mortality have not been studied.
Objectives: To examine the association between IR trajectories and incident HF and all-cause mortality in a nondiabetic population.
Methods: We studied 7835 nondiabetic participants from the Atherosclerosis Risk in Communities (ARIC) Study.
Background: Fasting glucose (FG) demonstrates dynamic fluctuations over time and is associated with cardiovascular outcomes, yet current research is limited by small sample sizes and relies solely on baseline glycemic levels. Our research aims to investigate the longitudinal association between FG and silent myocardial infarction (SMI) and also delves into the nuanced aspect of dose response in a large pooled dataset of four cohort studies.
Methods: We analyzed data from 24,732 individuals from four prospective cohort studies who were free of myocardial infarction history at baseline.
Heart failure (HF) prevention is an urgent public health need with national and global implications. Stage A HF patients do not show HF symptoms or structural heart disease but are at risk of HF development. There are no unique recommendations on detecting Stage A patients.
View Article and Find Full Text PDF